Merck Eprova AG
6Patents
4Active
6Granted
38Portfolio score
Filing activity: Jun 23, 2000 → May 10, 2010 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7727987B2 | Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride | Human Necessities | 15 | Expired |
| US7732599B2 | Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin | Chemistry; Metallurgy | 13 | Active |
| US8067416B2 | Methods and compositions for the treatment of metabolic disorders | Human Necessities | 12 | Active |
| US8344140B2 | 18F-labelled folates | Chemistry; Metallurgy | 4 | Active |
| US8344139B2 | Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride | Human Necessities | 0 | Active |
| US6849735B1 | Methods of synthesis for 9-substituted hypoxanthine derivatives | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.